Although this method is valid in many cases, there are conditions such as chronic renal disease, obesity, and during fasting in which directly measured IGF-I bioactivity may more closely reflect the endogenous IGF-I bioactivity. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.